bg
A

Akari Therapeutics (AKTX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Akari Therapeutics (AKTX)

Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activati... Read more

  • USD3.21
  • USD3.30
  • USD2.60
  • USD5.50
  • 96.30%
  • --
  • 43.93k
  • 29.70k
  • 27M
  • 1.08
  • 0.60%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.